David G. Mutch

ORCID: 0000-0002-6921-1581 · 4 papers in corpus · active 2013-2024

Study types

  • article 2
  • preprint 2
article 2024
Abstract PR003: The combination of the glucagon like peptide-1 receptor agonist semaglutide and the progestin levonorgestrel is highly effective in preclinical studies of endometrial cancer
·doi:10.1158/1557-3265.endo24-pr003

Abstract Obesity is a major risk factor for endometrial cancer (EC), and glucagon like peptide-1 receptor (GLP-1R) agonists such as semaglutide may be helpful to achieve weight loss during conservative treatment or for EC prevention. Proges…

preprint 2023
Supplementary Figures 1 - 13, Tables 1 - 5 from Promoter Hypomethylation of EpCAM-Regulated Bone Morphogenetic Protein Gene Family in Recurrent Endometrial Cancer
·doi:10.1158/1078-0432.22452648.v1

PDF file - 1049K, Supplementary Figure S1. Summarized sequencing reads and coverage of MBDCap-seq Supplementary Figure S2. Reproducibility test of MBDCap-seq Supplementary Figure S3. Validation of MBDCap-seq by MassARRAY analysis Supplement…

preprint 2023
Supplementary Figures 1 - 13, Tables 1 - 5 from Promoter Hypomethylation of EpCAM-Regulated Bone Morphogenetic Protein Gene Family in Recurrent Endometrial Cancer
·doi:10.1158/1078-0432.22452648

PDF file - 1049K, Supplementary Figure S1. Summarized sequencing reads and coverage of MBDCap-seq Supplementary Figure S2. Reproducibility test of MBDCap-seq Supplementary Figure S3. Validation of MBDCap-seq by MassARRAY analysis Supplement…

article 2013
Abstract 1378: Factors influencing survival in gynecologic oncology patients diagnosed with intestinal perforation and pneumatosis intestinalis.
·doi:10.1158/1538-7445.am2013-1378

Abstract Objective: To investigate the potential factors associated with survival in gynecologic oncology patients diagnosed with intestinal perforation and pneumatosis intestinalis. Methods: A retrospective chart review was performed of al…